Sign up to save your podcasts
Or
Share Principles and Strategies for Designing Best-in-Class Immuno-Oncology ADCs
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Principles and Strategies for Designing Best-in-Class Immuno-Oncology ADCs
About this podcast:
This podcast dives deep into the fundamentals of antibody-drug conjugate design, specifically focusing on the selection of targeting antibodies, cytotoxic drugs, and linkers. Presenter Dr Deepa Pakianathan highlights key strategies for constructing ADCs and the critical differentiating features that enhance therapeutic efficacy and safety.
For more information, go to IO360summit.com.
This podcast dives deep into the fundamentals of antibody-drug conjugate design, specifically focusing on the selection of targeting antibodies, cytotoxic drugs, and linkers. Presenter Dr Deepa Pakianathan highlights key strategies for constructing ADCs and the critical differentiating features that enhance therapeutic efficacy and safety.
For more information, go to IO360summit.com.
View all episodes
By Conference ForumAbout this podcast:
This podcast dives deep into the fundamentals of antibody-drug conjugate design, specifically focusing on the selection of targeting antibodies, cytotoxic drugs, and linkers. Presenter Dr Deepa Pakianathan highlights key strategies for constructing ADCs and the critical differentiating features that enhance therapeutic efficacy and safety.
For more information, go to IO360summit.com.
This podcast dives deep into the fundamentals of antibody-drug conjugate design, specifically focusing on the selection of targeting antibodies, cytotoxic drugs, and linkers. Presenter Dr Deepa Pakianathan highlights key strategies for constructing ADCs and the critical differentiating features that enhance therapeutic efficacy and safety.
For more information, go to IO360summit.com.